Xeris Biopharma Holdings, Inc.
XERS · XNASCIK 1867096fmd_05KZDG0ZB229VZ7HDWTR3MW5YQManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2026, 27 periods
AI-written
A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.
Loading